nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical Perspectives on Dose Escalation for Non–Small-Cell Lung Cancer
|
Chang, Albert J. |
|
2010 |
11 |
5 |
p. 299-302 4 p. |
artikel |
2 |
Comparison of 18F-Fluoroerythronitroimidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography and Prognostic Value in Locally Advanced Non–Small-Cell Lung Cancer
|
Li, Ling |
|
2010 |
11 |
5 |
p. 335-340 6 p. |
artikel |
3 |
Dr. David R. Gandara Receives Third Annual Addario Lectureship Award at International Lung Cancer Congress
|
Allen, David |
|
2010 |
11 |
5 |
p. 298- 1 p. |
artikel |
4 |
Expression and Clinicopathologic Significance of Proteolysis-Inducing Factor in Non–Small-Cell Lung Cancer: An Immunohistochemical Analysis
|
Wang, Qing |
|
2010 |
11 |
5 |
p. 346-351 6 p. |
artikel |
5 |
High N-Terminal Pro–B-Type Natriuretic Peptide: A Biomarker of Lung Cancer?
|
Aujollet, Nathalie |
|
2010 |
11 |
5 |
p. 341-345 5 p. |
artikel |
6 |
Low Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase mRNA Expression Correlate With Prolonged Survival in Resected Non–Small-Cell Lung Cancer
|
Grimminger, Peter P. |
|
2010 |
11 |
5 |
p. 328-334 7 p. |
artikel |
7 |
Second-line Treatment for Non–Small-Cell Lung Cancer: One Size Does Not Fit All
|
Caponi, Sara |
|
2010 |
11 |
5 |
p. 320-327 8 p. |
artikel |
8 |
Selected Clinical Trials in Lung Cancer
|
Langer, Corey J. |
|
2010 |
11 |
5 |
p. 358-359 2 p. |
artikel |
9 |
Small-Cell Carcinoma With an Epidermal Growth Factor Receptor Mutation in a Never-Smoker With Gefitinib-Responsive Adenocarcinoma of the Lung
|
Alam, Naheed |
|
2010 |
11 |
5 |
p. E1-E4 nvt p. |
artikel |
10 |
Supersensitive Mutation: Two Case Reports of Non–Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors
|
Myerson, James S. |
|
2010 |
11 |
5 |
p. E5-E8 nvt p. |
artikel |
11 |
The 2010 Meeting of the American Society of Clinical Oncology
|
Lee, David J. |
|
2010 |
11 |
5 |
p. 303-310 8 p. |
artikel |
12 |
Treatment Rationale and Study Design for a Randomized Trial of Pemetrexed/Carboplatin Followed by Maintenance Pemetrexed Versus Paclitaxel/Carboplatin/Bevacizumab Followed by Maintenance Bevacizumab in Patients With Advanced Non–Small-Cell Lung Cancer of Nonsquamous Histology
|
Zinner, Ralph G. |
|
2010 |
11 |
5 |
p. 352-357 6 p. |
artikel |
13 |
Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer
|
Subramanian, Janakiraman |
|
2010 |
11 |
5 |
p. 311-319 9 p. |
artikel |